Multiple mechanisms of microglia: A gatekeeper's contribution to pain states

Experimental Neurology

Volumn 234, Issue 2, 2012, Pages 255-261

  Graeber, Manuel B ^a   Christie, MacDonald J ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

CNS autonomous and specific mechanisms of microglial activation; Diseased microglia; Inflammation; Normal pain; Pathological pain

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CANNABINOID 1 RECEPTOR; CYCLOOXYGENASE 2; ENDOCANNABINOID; FRACTALKINE; GAMMA INTERFERON; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; MONOCYTE CHEMOTACTIC PROTEIN 1; PROSTAGLANDIN E2; PURINERGIC P2X4 RECEPTOR; PURINERGIC P2X7 RECEPTOR; ROSIGLITAZONE; STAT3 PROTEIN; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; VESICULAR GLUTAMATE TRANSPORTER 1;

ALLODYNIA; ASTROCYTOSIS; BLOOD BRAIN BARRIER; CD4+ T LYMPHOCYTE; CELL ACTIVATION; CELL FUNCTION; CELL INTERACTION; CELL LINEAGE; CELL PROLIFERATION; CHRONIC PAIN; DISEASE SEVERITY; DOWN REGULATION; HYPERALGESIA; INNATE IMMUNITY; KUPFFER CELL; LONG TERM DEPRESSION; MACROPHAGE; MICROGLIA; NERVE CELL PLASTICITY; NEUROPATHIC PAIN; NEUROTRANSMISSION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MOTIF; PROTEIN SECRETION; PROTEIN SYNTHESIS; REVIEW; SYNAPSE; SYNAPTIC TRANSMISSION; UPREGULATION;

ANIMALS; CHRONIC PAIN; ENDOCANNABINOIDS; HUMANS; INFLAMMATION; MICROGLIA; NEURALGIA;

EID: 84858155099     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2012.01.007     Document Type: Review

References (102)

1. Akoum A., Metz C.N., Al-Akoum M., Kats R. Macrophage migration inhibitory factor expression in the intrauterine endometrium of women with endometriosis varies with disease stage, infertility status, and pelvic pain. Fertil. Steril. 2006, 85:1379-1385.
2. Aloisi A.M., Pari G., Ceccarelli I., Vecchi I., Ietta F., Lodi L., Paulesu L. Gender-related effects of chronic non-malignant pain and opioid therapy on plasma levels of macrophage migration inhibitory factor (MIF). Pain 2005, 115:142-151.
3. Anand P., Whiteside G., Fowler C.J., Hohmann A.G. Targeting CB2 receptors and the endocannabinoid system for the treatment of pain. Brain Res. Rev. 2009, 60:255-266.
4. Ashton J.C., Glass M. The cannabinoid CB2 receptor as a target for inflammation-dependent neurodegeneration. Curr. Neuropharmacol. 2007, 5:73-80.
5. Berger J.V., Deumens R., Goursaud S., Schafer S., Lavand'homme P., Joosten E.A., Hermans E. Enhanced neuroinflammation and pain hypersensitivity after peripheral nerve injury in rats expressing mutated superoxide dismutase 1. J. Neuroinflammation 2011, 8:33.
6. Biber K., Tsuda M., Tozaki-Saitoh H., Tsukamoto K., Toyomitsu E., Masuda T., Boddeke H., Inoue K. Neuronal CCL21 up-regulates microglia P2X4 expression and initiates neuropathic pain development. EMBO J. 2011, 30:1864-1873.
7. Biggs J.E., Lu V.B., Stebbing M.J., Balasubramanyan S., Smith P.A. Is BDNF sufficient for information transfer between microglia and dorsal horn neurons during the onset of central sensitization?. Mol. Pain 2010, 6:44.
8. Bradesi S., Svensson C., Steinauer J., Pothoulakis C., Yaksh T., Mayer E. Role of spinal microglia in visceral hyperalgesia and NK1R up-regulation in a rat model of chronic stress. Gastroenterology 2008, 136:1339-1348.
9. Cao L., DeLeo J.A. CNS-infiltrating CD4+ T lymphocytes contribute to murine spinal nerve transection-induced neuropathic pain. Eur. J. Immunol. 2008, 38:448-458.
10. Choi H.K., Ryu H.J., Kim J.-E., Jo S.-M., Choi H.-C., Song H.-K., Kang T.-C. The roles of P2X7 receptor in regional-specific microglial responses in the rat brain following status epilepticus. Neurol. Sci. 2011, 10.1007/s10072-011-0740-z.
11. Christie M.J., Mallet C. Endocannainoids can open the pain gate. Sci. Signal. 2009, 2:pe57.
12. Clark, A. K., Staniland, A.A., Malcangio, M., in press. Fractalkine/CX3CR1 signalling in chronic pain and inflammation. Curr. Pharmaceutical Biotechnology.
13. Coull J.A.M., Boudreau D., Bachand K., Prescott S.A., Nault F., Sík A., De Koninck P., De Koninck Y. Trans-synaptic shift in anion gradient in spinal lamina I neurons as a mechanism of neuropathic pain. Nature 2003, 424:938-942.
14. Coull J.A.M., Beggs S., Boudreau D., Boivin D., Tsuda M., Inoue K., Gravel C., Salter M.W., De Koninck Y. BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain. Nature 2005, 438:1017-1021.
15. De Leo J.A., Tawfik V.L., Lacroix-Fralish M.L. The tetrapartite synapse: path to CNS sensitization and chronic pain. Pain 2006, 122:17-21.
16. Dominguez E., Rivat C., Pommier B., Mauborgne A., Pohl M. JAK/STAT3 pathway is activated in spinal cord microglia after peripheral nerve injury and contributes to neuropathic pain development in rat. J. Neurochem. 2008, 107:50-60.
17. Finnerup N.B. A review of central neuropathic pain states. Curr. Opin. Anaesthesiol. 2008, 21:586-589.
18. Gao Y.-J., Ji R.-R. Targeting astrocyte signaling for chronic pain. Neurotherapeutics 2010, 7:482-493.
19. Ginhoux F., Greter M., Leboeuf M., Nandi S., See P., Gokhan S., Mehler M.F., Conway S.J., Ng L.G., Stanley E.R., Samokhvalov I.M., Merad M. Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science 2010, 330:841-845.
20. Graeber M.B. Changing face of microglia. Science 2010, 330:783-788.
21. Graeber M.B., Streit W.J., Kreutzberg G.W. Axotomy of the rat facial nerve leads to increased CR3 complement receptor expression by activated microglial cells. J. Neurosci. Res. 1988, 21:18-24.
22. Graeber M.B., Wei L., Rodriguez M. Role of microglia in CNS inflammation FEBS Lett. 2011, 585(23):3798-3805. (Electronic publication ahead of print 2011 Aug 30).
23. Griffin R.S., Costigan M., Brenner G.J., Ma C.H.E., Scholz J., Moss A., Allchorne A.J., Stahl G.L., Woolf C.J. Complement induction in spinal cord microglia results in anaphylatoxin C5a-mediated pain hypersensitivity. J. Neurosci. 2007, 27:8699-8708.
24. Guasti L., Richardson D., Jhaveri M., Eldeeb K., Barrett D., Elphick M.R., Alexander S.P., Kendall D., Michael G.J., Chapman V. Minocycline treatment inhibits microglial activation and alters spinal levels of endocannabinoids in a rat model of neuropathic pain. Mol. Pain 2009, 5:35.
25. Guo L.-H., Trautmann K., Schluesener H.J. Expression of P2X4 receptor by lesional activated microglia during formalin-induced inflammatory pain. J. Neuroimmunol. 2005, 163:120-127.
26. He L., Li H., Chen L., Miao J., Jiang Y., Zhang Y., Xiao Z., Hanley G., Li Y., Zhang X., Lesage G., Peng Y., Yin D. Toll-like receptor 9 is required for opioid-induced microglia apoptosis. PLoS One 2011, 6:e18190.
27. He W.-J., Cui J., Du L., Zhao Y.-D., Burnstock G., Zhou H.-D., Ruan H.-Z. Spinal P2X7 receptor mediates microglia activation-induced neuropathic pain in the sciatic nerve injury rat model. Behav. Brain Res 2011, 10.1016/j.bbr.2011.09.015.
28. Heifets B.D., Castillo P.E. Endocannabinoid signaling and long-term synaptic plasticity. Annu. Rev. Physiol. 2009, 71:283-306.
29. Hinwood M., Morandini J., Day T.A., Walker F.R. Evidence that microglia mediate the neurobiological effects of chronic psychological stress on the medial prefrontal cortex. Cereb. Cortex 2011, 10.1093/cercor/bhr229.
30. Horvath R.J., Romero-Sandoval E.A., DeLeo J.A. Inhibition of microglial P2X4 receptors attenuates morphine tolerance, Iba1, GFAP and μ opioid receptor protein expression while enhancing perivascular microglial ED2. Pain 2010, 150:401-413.
31. Hulsebosch C.E. Gliopathy ensures persistent inflammation and chronic pain after spinal cord injury. Exp. Neurol. 2008, 214:6-9.
32. Inoue K. ATP receptors of microglia involved in pain. Novartis Found. Symp. 2006, 276:263-272. discussion 273-281.
33. Inoue K., Tsuda M. Microglia and neuropathic pain. Glia 2009, 57:1469-1479.
34. Kiguchi N., Maeda T., Kobayashi Y., Fukazawa Y., Kishioka S. Macrophage inflammatory protein-1alpha mediates the development of neuropathic pain following peripheral nerve injury through interleukin-1beta up-regulation. Pain 2010, 149:305-315.
35. Kim D., You B., Jo E.-K., Han S.-K., Simon M.I., Lee S.J. NADPH oxidase 2-derived reactive oxygen species in spinal cord microglia contribute to peripheral nerve injury-induced neuropathic pain. Proc. Natl. Acad. Sci. U S A 2010, 107:14851-14856.
36. Knerlich-Lukoschus F., Juraschek M., Blömer U., Lucius R., Mehdorn H.M., Held-Feindt J. Force-dependent development of neuropathic central pain and time-related CCL2/CCR2 expression after graded spinal cord contusion injuries of the rat. J. Neurotrauma 2008, 25:427-448.
37. Knerlich-Lukoschus F., Noack M., von der Ropp-Brenner B., Lucius R., Mehdorn H.M., Held-Feindt J. Spinal cord injuries induce changes in CB1 cannabinoid receptor and C-C chemokine expression in brain areas underlying circuitry of chronic pain conditions. J. Neurotrauma 2011, 28:619-634.
38. Kobayashi K., Yamanaka H., Fukuoka T., Dai Y., Obata K., Noguchi K. P2Y12 receptor upregulation in activated microglia is a gateway of p38 signaling and neuropathic pain. J. Neurosci. 2008, 28:2892-2902.
39. Kreutzberg G.W. Microglia: a sensor for pathological events in the CNS. Trends Neurosci. 1996, 19:312-318.
40. Kuzumaki N., Narita M., Narita M., Hareyama N., Niikura K., Nagumo Y., Nozaki H., Amano T., Suzuki T. Chronic pain-induced astrocyte activation in the cingulate cortex with no change in neural or glial differentiation from neural stem cells in mice. Neurosci. Lett. 2007, 415:22-27.
41. Lin T., Li K., Zhang F.-Y., Zhang Z.-K., Light A.R., Fu K.-Y. Dissociation of spinal microglia morphological activation and peripheral inflammation in inflammatory pain models. J. Neuroimmunol. 2007, 192:40-48.
42. Lindia J.A., McGowan E., Jochnowitz N., Abbadie C. Induction of CX3CL1 expression in astrocytes and CX3CR1 in microglia in the spinal cord of a rat model of neuropathic pain. J. Pain 2005, 6:434-438.
43. Louvet A., Teixeira-Clerc F., Chobert M.-N., Deveaux V., Pavoine C., Zimmer A., Pecker F., Mallat A., Lotersztajn S. Cannabinoid CB2 receptors protect against alcoholic liver disease by regulating Kupffer cell polarization in mice. Hepatology 2011, 10.1002/hep. 24524.
44. Ma W., Quirion R. Targeting invading macrophage-derived PGE2, IL-6 and calcitonin gene-related peptide in injured nerve to treat neuropathic pain. Expert Opin. Ther. Targets 2006, 10:533-546.
45. Mackie K. Distribution of cannabinoid receptors in the central and peripheral nervous system. Handb. Exp. Pharmacol. 2005, 168:299-325.
46. Maeda T., Kiguchi N., Kobayashi Y., Ikuta T., Ozaki M., Kishioka S. Leptin derived from adipocytes in injured peripheral nerves facilitates development of neuropathic pain via macrophage stimulation. Proc. Natl. Acad. Sci. U S A 2009, 106:13076-13081.
47. Mei X.-P., Xu H., Xie C., Ren J., Zhou Y., Zhang H., Xu L.-X. Post-injury administration of minocycline: an effective treatment for nerve-injury induced neuropathic pain. Neurosci. Res. 2011, 70:305-312.
48. Mert T., Gunay I., Ocal I., Guzel A.I., Inal T.C., Sencar L., Polat S. Macrophage depletion delays progression of neuropathic pain in diabetic animals. Naunyn Schmiedebergs Arch. Pharmacol. 2009, 379:445-452.
49. Michelucci A., Heurtaux T., Grandbarbe L., Morga E., Heuschling P. Characterization of the microglial phenotype under specific pro-inflammatory and anti-inflammatory conditions: effects of oligomeric and fibrillar amyloid-beta. J. Neuroimmunol. 2009, 210:3-12.
50. Mika J. Modulation of microglia can attenuate neuropathic pain symptoms and enhance morphine effectiveness. Pharmacol. Rep. 2008, 60:297-307.
51. Miraucourt L.S., Peirs C., Dallel R., Voisin D.L. Glycine inhibitory dysfunction turns touch into pain through astrocyte-derived d-serine. Pain 2011, 152:1340-1348.
52. Miyoshi K., Obata K., Kondo T., Okamura H., Noguchi K. Interleukin-18-mediated microglia/astrocyte interaction in the spinal cord enhances neuropathic pain processing after nerve injury. J. Neurosci. 2008, 28:12775-12787.
53. Muccioli G.G., Xu C., Odah E., Cudaback E., Cisneros J.A., Lambert D.M., Lopez Rodriguez M.L., Bajjalieh S., Stella N. Identification of a novel endocannabinoid-hydrolyzing enzyme expressed by microglial cells. J. Neurosci. 2007, 27:2883-2889.
54. Mulder J., Zilberter M., Pasquaré S.J., Alpár A., Schulte G., Ferreira S.G., Köfalvi A., Martín-Moreno A.M., Keimpema E., Tanila H., Watanabe M., Mackie K., Hortobágyi T., de Ceballos M.L., Harkany T. Molecular reorganization of endocannabinoid signalling in Alzheimer's disease. Brain 2011, 134:1041-1060.
55. Narita M., Yoshida T., Nakajima M., Narita M., Miyatake M., Takagi T., Yajima Y., Suzuki T. Direct evidence for spinal cord microglia in the development of a neuropathic pain-like state in mice. J. Neurochem. 2006, 97:1337-1348.
56. Narita M., Miyoshi K., Narita M., Suzuki T. Involvement of microglia in the ethanol-induced neuropathic pain-like state in the rat. Neurosci. Lett. 2007, 414:21-25.
57. Nimmerjahn A., Kirchhoff F., Helmchen F. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 2005, 308:1314-1318.
58. Obata K., Katsura H., Mizushima T., Sakurai J., Kobayashi K., Yamanaka H., Dai Y., Fukuoka T., Noguchi K. Roles of extracellular signal-regulated protein kinases 5 in spinal microglia and primary sensory neurons for neuropathic pain. J. Neurochem. 2007, 102:1569-1584.
59. O'Callaghan J.P., Miller D.B. Spinal glia and chronic pain. Metab. Clin. Exp. 2010, 59(Suppl. 1):S21-S26.
60. Pacher P. The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol. Rev. 2006, 58:389-462.
61. Panigada T., Gosselin R.-D. Behavioural alteration in chronic pain: are brain glia involved?. Med. Hypotheses 2011, 10.1016/j.mehy.2011.06.036.
62. Pernia-Andrade A.J., Kato A., Witschi R., Nyilas R., Katona I., Freund T.F., Watanabe M., Filitz J., Koppert W., Schuttler J., Ji G., Neugebauer V., Marsicano G., Lutz B., Vanegas H., Zeilhofer H.U. Spinal endocannabinoids and CB1 receptors mediate C-fiber-induced heterosynaptic pain sensitization. Science 2009, 325:760-764.
63. Perry V.H. Contribution of systemic inflammation to chronic neurodegeneration. Acta Neuropathol. 2010, 120:277-286.
64. Racz I., Nadal X., Alferink J., Baños J.E., Rehnelt J., Martín M., Pintado B., Gutierrez-Adan A., Sanguino E., Manzanares J., Zimmer A., Maldonado R. Crucial role of CB(2) cannabinoid receptor in the regulation of central immune responses during neuropathic pain. J. Neurosci. 2008, 28:12125-12135.
65. Raghavendra V., Tanga F., DeLeo J.A. Inhibition of microglial activation attenuates the development but not existing hypersensitivity in a rat model of neuropathy. J. Pharmacol. Exp. Ther. 2003, 306:624-630.
66. Romero-Sandoval A., Chai N., Nutile-McMenemy N., DeLeo J.A. A comparison of spinal Iba1 and GFAP expression in rodent models of acute and chronic pain. Brain Res. 2008, 1219:116-126.
67. Romero-Sandoval A., Nutile-McMenemy N., DeLeo J.A. Spinal microglial and perivascular cell cannabinoid receptor type 2 activation reduces behavioral hypersensitivity without tolerance after peripheral nerve injury. Anesthesiology 2008, 108:722-734.
68. Romero-Sandoval E., Horvath R., Landry R., Deleo J. Cannabinoid receptor type 2 activation induces a microglial anti-inflammatory phenotype and reduces migration via MKP induction and ERK dephosphorylation. Mol. Pain 2009, 5:25.
69. Rothoerl R.D., Woertgen C., Brawanski A. Pain resolution after lumbar disc surgery is influenced by macrophage tissue infiltration. A prospective consecutive study on 177 patients. J. Clin. Neurosci. 2002, 9:633-636.
70. Sagar D.R., Jhaveri M.D., Richardson D., Gray R.A., De Lago E., Fernández-Ruiz J., Barrett D.A., Kendall D.A., Chapman V. Endocannabinoid regulation of spinal nociceptive processing in a model of neuropathic pain. Eur. J. Neurosci. 2010, 31:1414-1422.
71. Saito O., Svensson C.I., Buczynski M.W., Wegner K., Hua X.-Y., Codeluppi S., Schaloske R.H., Deems R.A., Dennis E.A., Yaksh T.L. Spinal glial TLR4-mediated nociception and production of prostaglandin E(2) and TNF. Br. J. Pharmacol. 2010, 160:1754-1764.
72. Sandkuhler J. Models and mechanisms of hyperalgesia and allodynia. Physiol. Rev. 2009, 89:707-758.
73. Smith H.S. Activated microglia in nociception. Pain Physician 2010, 13:295-304.
74. Stella N. Endocannabinoid signaling in microglial cells. Neuropharmacology 2009, 56:244-253.
75. Stevens B., Allen N.J., Vazquez L.E., Howell G.R., Christopherson K.S., Nouri N., Micheva K.D., Mehalow A.K., Huberman A.D., Stafford B., Sher A., Litke A.M., Lambris J.D., Smith S.J., John S.W.M., Barres B.A. The classical complement cascade mediates CNS synapse elimination. Cell 2007, 131:1164-1178.
76. Sumislawski J.J., Ramikie T.S., Patel S. Reversible gating of endocannabinoid plasticity in the amygdala by chronic stress: a potential role for monoacylglycerol lipase inhibition in the prevention of stress-induced behavioral adaptation. Neuropsychopharmacology 2011, 10.1038/npp. 2011.166.
77. Takahashi Y., Hasegawa-Moriyama M., Sakurai T., Inada E. The macrophage-mediated effects of the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone attenuate tactile allodynia in the early phase of neuropathic pain development. Anesth. Analg 2011, 10.1213/ANE.0b013e31821b220c.
78. Thacker M.A., Clark A.K., Bishop T., Grist J., Yip P.K., Moon L.D.F., Thompson S.W.N., Marchand F., McMahon S.B. CCL2 is a key mediator of microglia activation in neuropathic pain states. Eur. J. Pain 2009, 13:263-272.
79. Toda S., Sakai A., Ikeda Y., Sakamoto A., Suzuki H. A local anesthetic, ropivacaine, suppresses activated microglia via a nerve growth factor-dependent mechanism and astrocytes via a nerve growth factor-independent mechanism in neuropathic pain. Mol. Pain 2011, 7:2.
80. Tozaki-Saitoh H., Tsuda M., Miyata H., Ueda K., Kohsaka S., Inoue K. P2Y12 receptors in spinal microglia are required for neuropathic pain after peripheral nerve injury. J. Neurosci. 2008, 28:4949-4956.
81. Trang T., Beggs S., Wan X., Salter M.W. P2X4-receptor-mediated synthesis and release of brain-derived neurotrophic factor in microglia is dependent on calcium and p38-mitogen-activated protein kinase activation. J. Neurosci. 2009, 29:3518-3528.
82. Treede R.-D., Jensen T.S., Campbell J.N., Cruccu G., Dostrovsky J.O., Griffin J.W., Hansson P., Hughes R., Nurmikko T., Serra J. Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology 2008, 70:1630-1635.
83. Tremblay M.È., Lowery R.L., Majewska A.K. Microglial interactions with synapses are modulated by visual experience. PLoS Biol. 2010, 8(11):e1000527.
84. Tsuda M., Masuda T., Kitano J., Shimoyama H., Tozaki-Saitoh H., Inoue IFN-{gamma} receptor signaling mediates spinal microglia activation driving neuropathic pain. Proc. Natl. Acad. Sci. U S A 2009, 106:8032-8037.
85. Tsuda M., Kohro Y., Yano T., Tsujikawa T., Kitano J., Tozaki-Saitoh H., Koyanagi S., Ohdo S., Ji R.-R., Salter M.W., Inoue K. JAK-STAT3 pathway regulates spinal astrocyte proliferation and neuropathic pain maintenance in rats. Brain 2011, 134:1127-1139.
86. Ulmann L., Hatcher J.P., Hughes J.P., Chaumont S., Green P.J., Conquet F., Buell G.N., Reeve A.J., Chessell I.P., Rassendren F. Up-regulation of P2X4 receptors in spinal microglia after peripheral nerve injury mediates BDNF release and neuropathic pain. J. Neurosci. 2008, 28:11263-11268.
87. Wake H., Moorhouse A.J., Jinno S., Kohsaka S., Nabekura J. Resting microglia directly monitor the functional state of synapses in vivo and determine the fate of ischemic terminals. J. Neurosci. 2009, 29:3974-3980.
88. Walter L., Franklin A., Witting A., Wade C., Xie Y., Kunos G., Mackie K., Stella N. Nonpsychotropic cannabinoid receptors regulate microglial cell migration. J. Neurosci. 2003, 23:1398-1405.
89. Wang W., Wang W., Wang Y., Huang J., Wu S., Li Y.-Q. Temporal changes of astrocyte activation and glutamate transporter-1 expression in the spinal cord after spinal nerve ligation-induced neuropathic pain. Anat. Rec. 2008, 291:513-518.
90. Wang F., Xu S., Shen X., Guo X., Peng Y., Yang J. Spinal macrophage migration inhibitory factor is a major contributor to rodent neuropathic pain-like hypersensitivity. Anesthesiology 2011, 114:643-659.
91. Watabe M., Kato T.A., Monji A., Horikawa H., Kanba S. Does minocycline, an antibiotic with inhibitory effects on microglial activation, sharpen a sense of trust in social interaction?. Psychopharmacology 2011, 10.1007/s00213-011-2509-8.
92. Witting A., Walter L., Wacker J., Möller T., Stella N. P2X7 receptors control 2-arachidonoylglycerol production by microglial cells. Proc. Natl. Acad. Sci. U S A 2004, 101:3214-3219.
93. Wohleb E.S., Hanke M.L., Corona A.W., Powell N.D., Stiner L.t.M., Bailey M.T., Nelson R.J., Godbout J.P., Sheridan J.F. {beta}-Adrenergic receptor antagonism prevents anxiety-like behavior and microglial reactivity induced by repeated social defeat. J. Neurosci. 2011, 31:6277-6288.
94. Zhang J., Shi X.Q., Echeverry S., Mogil J.S., De Koninck Y., Rivest S. Expression of CCR2 in both resident and bone marrow-derived microglia plays a critical role in neuropathic pain. J. Neurosci. 2007, 27:12396-12406.
95. Zhang J., Cheng H., Chen Yi F., Li W., Luan R., Guo W., Lv A., Rao Z., Wang H. Involvement of activated astrocyte and microglia of locus coeruleus in cardiac pain processing after acute cardiac injury. Neurol. Res. 2009, 31:432-438.
96. Zhang Y., Li H., Li Y., Sun X., Zhu M., Hanley G., Lesage G., Yin D. Essential role of Toll-like receptor 2 in morphine-induced microglia activation in mice. Neurosci. Lett 2010, 10.1016/j.neulet.2010.11.063.
97. Zhang X., Xu Y., Wang J., Zhou Q., Pu S., Jiang W., Du D. The effect of intrathecal administration of glial activation inhibitors on dorsal horn BDNF overexpression and hind paw mechanical allodynia in spinal nerve ligated rats. J. Neural Transm 2011, 10.1007/s00702-011-0713-7.
98. Zhao P., Waxman S.G., Hains B.C. Extracellular signal-regulated kinase-regulated microglia-neuron signaling by prostaglandin E2 contributes to pain after spinal cord injury. J. Neurosci. 2007, 27:2357-2368.
99. Zhao P., Waxman S.G., Hains B.C. Modulation of thalamic nociceptive processing after spinal cord injury through remote activation of thalamic microglia by cysteine cysteine chemokine ligand 21. J. Neurosci. 2007, 27:8893-8902.
100. Zheng F.Y., Xiao W.-H., Bennett G.J. The response of spinal microglia to chemotherapy-evoked painful peripheral neuropathies is distinct from that evoked by traumatic nerve injuries. Neuroscience 2011, 176:447-454.
101. Zhou D., Chen M.-L., Zhang Y.-Q., Zhao Z.-Q. Involvement of spinal microglial P2X7 receptor in generation of tolerance to morphine analgesia in rats. J. Neurosci. 2010, 30:8042-8047.
102. Zhuang Z.-Y., Gerner P., Woolf C.J., Ji R.-R. ERK is sequentially activated in neurons, microglia, and astrocytes by spinal nerve ligation and contributes to mechanical allodynia in this neuropathic pain model. Pain 2005, 114:149-159.